Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Resistant Hypertension (RH) - Competitive Landscape
... in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for RH. The marketed drugs space for RH is dominated by off-label antihypertensive therapies. The R&D activity is limited within the RH space, with ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
... including regulatory, clinical, and market dynamics. The report identifies the broader changes within the evolving psychedelic industry, facilitating informed decision-making for relevant sectors. Scope This 36-page report gives important, expert insight you won’t find in ... Read More
-
Global AI in Drug Discovery Market 2024
... and predictive analytics, pharmaceutical companies can expedite the discovery of innovative therapeutics, improve patient outcomes, and address unmet medical needs more effectively. The global AI in drug discovery market was valued at USD 991.2 million ... Read More
-
Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
5-Alpha Reductase Inhibitor - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Transverse Myelitis - Pipeline Insight, 2024
... picture of the Transverse Myelitis pipeline landscape is provided, which includes the disease overview and Transverse Myelitis treatment guidelines. The assessment part of the report embraces in-depth Transverse Myelitis commercial assessment and clinical assessment of ... Read More
-
5-HT2B Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
20s Proteasome Inhibitor - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
2024 Global Cancer Supportive Care Drugs Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
5-HT6 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2024
... growth prospects across the Urinary Incontinence Including Neurogenic Bladder market. A detailed picture of the Urinary Incontinence Including Neurogenic Bladder pipeline landscape is provided, which includes the disease overview and Urinary Incontinence Including Neurogenic Bladder ... Read More
-
Uveal Neoplasms - Pipeline Insight, 2024
... picture of the Uveal Neoplasms pipeline landscape is provided, which includes the disease overview and Uveal Neoplasms treatment guidelines. The assessment part of the report embraces in-depth Uveal Neoplasms commercial assessment and clinical assessment of ... Read More
-
5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024
... 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, ... Read More
-
5-HT4 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Urolithiasis - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Urolithiasis treatment guidelines. The assessment part of the report embraces in-depth Urolithiasis commercial assessment and clinical assessment of the Urolithiasis pipeline products from the pre-clinical ... Read More
-
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Selectin Inhibitor - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Serotonin Transporter Inhibitor - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024
... Inhibitor (SRI) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Severe Hypoglycemia - Pipeline Insight, 2024
... picture of the Severe Hypoglycemia pipeline landscape is provided, which includes the disease overview and Severe Hypoglycemia treatment guidelines. The assessment part of the report embraces in-depth Severe Hypoglycemia commercial assessment and clinical assessment of ... Read More
-
Retinitis Pigmentosa- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Retinitis ... Read More
-
Focal Segmental Glomerulosclerosis (FSGS) - Epidemiology Forecast - 2034
... US. According to the analysis conducted by DelveInsight’s, FSGS was diagnosed in approximately 60% males and 48% of females within the 7MM in 2022. This analysis indicates a higher prevalence of FSGS among males than ... Read More
-
Staphylococcus Aureus Infection - Pipeline Insight, 2024
... Infection market. A detailed picture of the Staphylococcus Aureus Infection pipeline landscape is provided, which includes the disease overview and Staphylococcus Aureus Infection treatment guidelines. The assessment part of the report embraces in-depth Staphylococcus Aureus ... Read More
-
Anorexia Nervosa - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
Research Assistance
